Precision Medicine Companies

Tempus AI

Chicago, United States

Tempus provides a platform combining comprehensive clinical and molecular data with artificial intelligence, primarily serving the oncology space. Their core offering is an operating system built upon the world’s largest library of such data, enhanced by recent advancements in generative AI like their clinical co-pilot, David, and digital pathology capabilities acquired through Paige. Tempus targets physicians, pharmaceutical companies, and patients seeking data-driven insights to improve cancer treatment decisions and accelerate drug development.

iCarbonX

Shenzhen, China

iCarbonX develops a comprehensive digital health platform, utilizing its core product, the iCarbonX Apollo system, to integrate multi-omics data – including genomics, metabolomics, and microbiome analysis – with data from wearable sensors and user-reported health information. Their AI capabilities focus on developing predictive models for disease risk assessment and personalized health management, leveraging deep learning algorithms to identify biomarkers and patterns indicative of early-stage health concerns. Initially focused on the Chinese market, iCarbonX aims to provide preventative healthcare solutions and has notably partnered with hospitals and research institutions to validate its AI-driven health insights.

BPGbio

Framingham, United States

BPGbio uses AI and causal machine learning for drug discovery and development. Named 2024 BioTech AI Company of the Year.